Breaking Barriers to Care

May 19, 2020

Overview:

This symposium will explore race in the estimation of kidney function and how to increase patient participation in clinical trials.

test

Speakers:

James R. Gavin, PhD, MD
Emory University School of Medicine

Dr. James Gavin is chief medical officer of Healing Our Village, Inc., in Atlanta, Georgia, a company that specializes in targeted advocacy, training, education, and outreach for healthcare professionals and minority communities. He is also a clinical professor of medicine at Emory University School of Medicine in Atlanta, Georgia, and at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Gavin is also chairman of the board of Partnership for a Healthier America, an independent, not-for-profit group working with the private sector to reduce childhood obesity. He belongs to numerous organizations, including the National Academy of Medicine of the National Academies of Sciences, the American Association of Clinical Endocrinologists, and the American Diabetes Association, of which he is a past president. Dr. Gavin has authored or co-authored more than 250 articles and abstracts in publications such as Science, the Journal of Applied Physiology, Diabetes, and the American Journal of Physiology, and has served on many advisory boards and on the editorial board of the American Journal of the Medical Sciences, US Endocrinology, and the American Journal of Physiology. Dr. Gavin was named “A Living Legend in Diabetes” by the American Association of Diabetes Educators in 2009 and is a 2015 Recipient of the Lifetime Achievement in Diabetes Research Award from the American Diabetes Association.

Nwamaka D. Eneanya, MD, MPH
University of Pennsylvania

Nwamaka Eneanya, MD, MPH, FASN is currently an attending nephrologist and Assistant Professor of Medicine at the University of Pennsylvania. She is a clinical investigator with research interests that center on palliative care, informed decision-making and health equity among patients with advanced chronic kidney disease and end-stage kidney disease.  Her work has been supported by NIDDK, NIMHD, and the American Society of Nephrology Foundation for Kidney Research.

Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!